MICHELLE DENETTE: Open Payments
NPI 1801318498 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 25 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $264 · 2025 $502
Food & beverage: $433Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $179 |
| Astellas Pharma US Inc | 1 | $69 |
| Merck Sharp & Dohme LLC | 4 | $63 |
| Melinta Therapeutics, LLC | 1 | $30 |
| Shionogi Inc | 1 | $30 |
| Grifols USA, LLC | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Insmed, Inc. | 1 | $19 |
| Verona Pharma, Inc. | 1 | $17 |
Products named: EMBLAVEO, AVYCAZ, Rezzayo, Fetroja, PREVYMIS, Prolastin-C Liquid, PREVNAR 20, PIFELTRO.
Industry payments across LA — which companies pay providers there.
